These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 11672950)

  • 1. Changes in dopamine receptor responsivity during alcohol detoxification may predict relapse.
    Markianos M; Lykouras L; Moussas G; Hatzimanolis J
    Drug Alcohol Depend; 2001 Nov; 64(3):363-5. PubMed ID: 11672950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine receptor responsivity in alcoholic patients before and after detoxification.
    Markianos M; Moussas G; Lykouras L; Hatzimanolis J
    Drug Alcohol Depend; 2000 Jan; 57(3):261-5. PubMed ID: 10661677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolactin serum levels during alcohol withdrawal are associated with the severity of alcohol dependence and withdrawal symptoms.
    Wilhelm J; Heberlein A; Karagülle D; Gröschl M; Kornhuber J; Riera R; Frieling H; Bleich S; Hillemacher T
    Alcohol Clin Exp Res; 2011 Feb; 35(2):235-9. PubMed ID: 21121933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroendocrine serotonergic and dopaminergic responsivity in male schizophrenic patients during treatment with neuroleptics and after switch to risperidone.
    Markianos M; Hatzimanolis J; Lykouras L
    Psychopharmacology (Berl); 2001 Aug; 157(1):55-9. PubMed ID: 11512043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum prolactin correlates with depressed mood during alcohol withdrawal.
    Miller F; Barasch A; Sacks M; Levitan J; Ashcroft L
    Drug Alcohol Depend; 1986 Jul; 17(4):331-8. PubMed ID: 3757769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of alcohol detoxification on dopamine D2 receptors in alcoholics: a preliminary study.
    Volkow ND; Wang GJ; Maynard L; Fowler JS; Jayne B; Telang F; Logan J; Ding YS; Gatley SJ; Hitzemann R; Wong C; Pappas N
    Psychiatry Res; 2002 Dec; 116(3):163-72. PubMed ID: 12477600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Partial agonist properties of the antipsychotics SSR181507, aripiprazole and bifeprunox at dopamine D2 receptors: G protein activation and prolactin release.
    Cosi C; Carilla-Durand E; Assié MB; Ormiere AM; Maraval M; Leduc N; Newman-Tancredi A
    Eur J Pharmacol; 2006 Mar; 535(1-3):135-44. PubMed ID: 16554049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inverse agonism at dopamine D2 receptors. Haloperidol-induced prolactin release from GH4C1 cells transfected with the human D2 receptor is antagonized by R(-)-n-propylnorapomorphine, raclopride, and phenoxybenzamine.
    Nilsson CL; Ekman A; Hellstrand M; Eriksson E
    Neuropsychopharmacology; 1996 Jul; 15(1):53-61. PubMed ID: 8797192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prolactin response to sulpiride in major depression: the role of the D2 receptor in depression.
    Verbeeck WJ; Berk M; Paiker J; Jersky B
    Eur Neuropsychopharmacol; 2001 Jun; 11(3):215-20. PubMed ID: 11418281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between prolactin responses to ECT and dopaminergic and serotonergic responsivity in depressed patients.
    Markianos M; Hatzimanolis J; Lykouras L
    Eur Arch Psychiatry Clin Neurosci; 2002 Aug; 252(4):166-71. PubMed ID: 12242577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain-derived neurotrophic factor serum levels in alcohol-dependent subjects 6 months after alcohol withdrawal.
    Costa MA; Girard M; Dalmay F; Malauzat D
    Alcohol Clin Exp Res; 2011 Nov; 35(11):1966-73. PubMed ID: 21848960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lisuride, a dopamine D2 receptor agonist, and anticraving drug expectancy as modifiers of relapse in alcohol dependence.
    Schmidt LG; Kuhn S; Smolka M; Schmidt K; Rommelspacher H
    Prog Neuropsychopharmacol Biol Psychiatry; 2002 Feb; 26(2):209-17. PubMed ID: 11817496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. D(2) dopamine receptor (DRD2) polymorphism is associated with severity of alcohol dependence.
    Connor JP; Young RM; Lawford BR; Ritchie TL; Noble EP
    Eur Psychiatry; 2002 Mar; 17(1):17-23. PubMed ID: 11918988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IGF-I and IGFBP-3 before and after inpatient alcohol detoxification in alcohol-dependent subjects.
    Ilias I; Paparrigopoulos T; Tzavellas E; Karaiskos D; Kontoleon P; Liappas I
    Med Sci Monit; 2011 Oct; 17(10):CR547-51. PubMed ID: 21959607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. D2 but not D3 receptors are elevated after 9 or 11 months chronic haloperidol treatment: influence of withdrawal period.
    Joyce JN
    Synapse; 2001 May; 40(2):137-44. PubMed ID: 11252025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolactin secretion in response to haloperidol challenge in delusional (psychotic) and non-delusional depression.
    Lykouras L; Markianos M; Hatzimanolis J; Oulis P; Christodoulou G
    Eur Psychiatry; 2000 Dec; 15(8):480-2. PubMed ID: 11175925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced dopaminergic function in alcoholics is related to severe dependence.
    Schmidt LG; Dettling M; Graef KJ; Heinz A; Kuhn S; Podschus J; Rommelspacher H
    Biol Psychiatry; 1996 Feb; 39(3):193-8. PubMed ID: 8837980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Striatal dopaminergic D(2) receptor density measured by [(123)I]iodobenzamide SPECT in the prediction of treatment outcome of alcohol-dependent patients.
    Guardia J; Catafau AM; Batlle F; Martín JC; Segura L; Gonzalvo B; Prat G; Carrió I; Casas M
    Am J Psychiatry; 2000 Jan; 157(1):127-9. PubMed ID: 10618027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Personality traits predict treatment outcome in alcohol-dependent patients.
    Müller SE; Weijers HG; Böning J; Wiesbeck GA
    Neuropsychobiology; 2008; 57(4):159-64. PubMed ID: 18654085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine receptor responsivity in schizophrenic patients before and after switch from haloperidol to risperidone.
    Markianos M; Hatzimanolis J; Lykouras L
    Psychiatry Res; 1999 Dec; 89(2):115-22. PubMed ID: 10646830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.